National Disease Research Interchange
NDRI is a not-for-profit organization with over 40 years of experience providing human organs and tissue from diverse donors to support biomedical research. They partner with donation programs to obtain biospecimens for scientific research, utilizing a prospective procurement model and project-specific collection protocols. NDRI's mission is to advance biomedical and bioscience research and development worldwide by providing high-quality biospecimens.
Industries
Nr. of Employees
small (1-50)
National Disease Research Interchange
Philadelphia, Pennsylvania, United States
Products
Bioinventory (searchable catalog of stored biospecimens)
Indexed and searchable inventory of select frozen and fixed human biospecimens available to approved investigators, including metadata on preservation and donor attributes.
Programmatic tissue resources for large-scale research
Coordinated tissue resource programs and recovery services designed to supply standardized, high-volume tissues for multi-site research initiatives and grant-funded projects.
Developmental Genotype–Tissue Expression project support (dGTEx)
Specimen collection and provisioning aligned to a project establishing a public resource correlating gene expression and genetic variation in pediatric tissues across organ systems.
Surgical Discard
Inventory of excised samples from living donors who had surgical removal of tissue, such as cancerous tumors, preserved as formalin fixed, paraffin embedded (FFPE) blocks.
Surgical Discard Tissue Procurement
Procurement of surgical discard tissues such as tumor samples, full-thickness skin, umbilical cord, and placenta with a post-surgical interval of less than 4 hours.
Human Ocular Histological Section 0067833
Human ocular histological tissue sample from a donor with Glaucoma, Macular Degeneration (dry), and Peripheral Chorioretinal Atrophy, with RRIDs SAMN46163702 and SAMN46163703.
Bioinventory (searchable catalog of stored biospecimens)
Indexed and searchable inventory of select frozen and fixed human biospecimens available to approved investigators, including metadata on preservation and donor attributes.
Programmatic tissue resources for large-scale research
Coordinated tissue resource programs and recovery services designed to supply standardized, high-volume tissues for multi-site research initiatives and grant-funded projects.
Developmental Genotype–Tissue Expression project support (dGTEx)
Specimen collection and provisioning aligned to a project establishing a public resource correlating gene expression and genetic variation in pediatric tissues across organ systems.
Surgical Discard
Inventory of excised samples from living donors who had surgical removal of tissue, such as cancerous tumors, preserved as formalin fixed, paraffin embedded (FFPE) blocks.
Surgical Discard Tissue Procurement
Procurement of surgical discard tissues such as tumor samples, full-thickness skin, umbilical cord, and placenta with a post-surgical interval of less than 4 hours.
Human Ocular Histological Section 0067833
Human ocular histological tissue sample from a donor with Glaucoma, Macular Degeneration (dry), and Peripheral Chorioretinal Atrophy, with RRIDs SAMN46163702 and SAMN46163703.
Services
On-demand recovery and nationwide shipment of research-authorized human organs and tissues according to project-specific protocols.
Round-the-clock coordination and administrative support to operationalize donor notification, recovery, centralized processing and specimen shipment.
Provision and management of consent/authorization documents, donor history intake, eligibility screening and options for linking donation data to research registries under IRB-compliant processes.
Centralized processing pipelines for frozen and fixed specimens with precision aliquoting, spatial/sample tracking and continuous temperature-monitored long-term storage.
Operational and specimen-support services for NIH-funded consortia and multi-site research initiatives, including coordination of program-specific collection protocols and grant-aligned resource delivery.
Partnership services and workflow integration for organ and tissue recovery organizations to align donation opportunities with research needs while respecting clinical priorities.
On-demand recovery and nationwide shipment of research-authorized human organs and tissues according to project-specific protocols.
Round-the-clock coordination and administrative support to operationalize donor notification, recovery, centralized processing and specimen shipment.
Provision and management of consent/authorization documents, donor history intake, eligibility screening and options for linking donation data to research registries under IRB-compliant processes.
Centralized processing pipelines for frozen and fixed specimens with precision aliquoting, spatial/sample tracking and continuous temperature-monitored long-term storage.
Operational and specimen-support services for NIH-funded consortia and multi-site research initiatives, including coordination of program-specific collection protocols and grant-aligned resource delivery.
Partnership services and workflow integration for organ and tissue recovery organizations to align donation opportunities with research needs while respecting clinical priorities.
Expertise Areas
- Biospecimen procurement and nationwide logistics
- Biobanking and curated repository management
- Cold chain and monitored storage systems
- Sample processing, precision aliquoting and traceability
Key Technologies
- Searchable biorepository inventory systems with indexed metadata
- End-to-end cold chain monitoring and temperature-controlled logistics
- Precision aliquoting and spatial/sample tracking workflows
- Primary human tissue and cell preparation pipelines
News & Updates
NDRI has elected Marianne Henderson, MS, CPC, ELI-MP, PMP, to its Board of Directors. Henderson is the Senior Advisor at the National Cancer Institute’s Division of Cancer Epidemiology and Genetics (DCEG) at NIH.
NDRI joins a coalition urging Congress to oppose proposed NIH funding cuts that could harm biomedical research.
NDRI launched the NHBODP to support research into hearing, balance, and communication disorders, supported by NIH’s NIDCD.
Research supported by NDRI as part of the NIH SMaHT Network has been published in Nature, mapping somatic mutations across human tissues.
NDRI promoted Dr. Patrick Van Hoose to lead NIH initiatives, including the dGTEx program, enhancing collaboration and biospecimen access.
NDRI has elected Marianne Henderson, MS, CPC, ELI-MP, PMP, to its Board of Directors. Henderson is the Senior Advisor at the National Cancer Institute’s Division of Cancer Epidemiology and Genetics (DCEG) at NIH.
NDRI joins a coalition urging Congress to oppose proposed NIH funding cuts that could harm biomedical research.
NDRI launched the NHBODP to support research into hearing, balance, and communication disorders, supported by NIH’s NIDCD.
Research supported by NDRI as part of the NIH SMaHT Network has been published in Nature, mapping somatic mutations across human tissues.
NDRI promoted Dr. Patrick Van Hoose to lead NIH initiatives, including the dGTEx program, enhancing collaboration and biospecimen access.